PNC
AZN icon

Park National Corp’s AstraZeneca AZN Stock Holding History

Park National Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
71,820
-1,511
-2% -$284K 0.38% 72
2026
Q1 		$14.5M Buy
73,331
+3,612
+5% +$696K 0.44% 63
2025
Q4 		$12.8M Sell
69,719
-10,081
-13% -$1.77M 0.4% 65
2025
Q3 		$12.2M Buy
79,800
+5,198
+7% +$787K 0.38% 68
2025
Q2 		$10.4M Buy
74,602
+739
+1% +$104K 0.34% 72
2025
Q1 		$10.9M Sell
73,863
-3,203
-4% -$463K 0.4% 67
2024
Q4 		$10.1M Buy
77,066
+455
+0.6% +$63.7K 0.37% 64
2024
Q3 		$11.9M Sell
76,611
-4,080
-5% -$659K 0.42% 64
2024
Q2 		$12.6M Buy
80,691
+9,749
+14% +$1.47M 0.47% 58
2024
Q1 		$9.61M Sell
70,942
-2,131
-3% -$282K 0.37% 65
2023
Q4 		$9.84M Buy
73,073
+3,598
+5% +$468K 0.4% 68
2023
Q3 		$9.41M Sell
69,475
-901
-1% -$123K 0.43% 66
2023
Q2 		$10.1M Sell
70,376
-4,084
-5% -$601K 0.44% 65
2023
Q1 		$10.3M Sell
74,460
-943
-1% -$127K 0.46% 65
2022
Q4 		$10.2M Buy
75,403
+35,029
+87% +$4.39M 0.46% 63
2022
Q3 		$4.43M Sell
40,374
-534
-1% -$67.7K 0.22% 86
2022
Q2 		$5.41M Sell
40,908
-7,077
-15% -$929K 0.26% 82
2022
Q1 		$6.37M Sell
47,985
-6,837
-12% -$820K 0.26% 80
2021
Q4 		$6.39M Sell
54,822
-12,794
-19% -$1.51M 0.25% 81
2021
Q3 		$8.12M Sell
67,616
-15,576
-19% -$1.81M 0.34% 75
2021
Q2 		$9.97M Sell
83,192
-71,756
-46% -$7.87M 0.42% 70
2021
Q1 		$15.4M Buy
154,948
+306
+0.2% +$30.8K 0.68% 46
2020
Q4 		$15.5M Buy
154,642
+3,172
+2% +$336K 0.72% 44
2020
Q3 		$16.6M Sell
151,470
-1,088
-0.7% -$121K 0.87% 34
2020
Q2 		$16.1M Sell
152,558
-6,337
-4% -$654K 0.9% 33
2020
Q1 		$14.2M Buy
158,895
+1,507
+1% +$142K 0.9% 38
2019
Q4 		$15.7M Buy
157,388
+5,039
+3% +$474K 0.8% 41
2019
Q3 		$13.6M Buy
152,349
+13,213
+9% +$1.15M 0.74% 41
2019
Q2 		$11.5M Buy
139,136
+20,196
+17% +$1.58M 0.62% 44
2019
Q1 		$9.62M Buy
118,940
+31,199
+36% +$2.46M 0.54% 49
2018
Q4 		$6.67M Buy
87,741
+50,056
+133% +$3.91M 0.41% 54
2018
Q3 		$2.98M Buy
+37,685
New +$2.85M 0.16% 90

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Park National Corp's AZN Position: Q2 2026 in Review

Park National Corp reduced its AstraZeneca (AZN) stake by 2.1% in Q2 2026, selling an estimated $284K and leaving 71,820 shares worth $13.6M. The position accounts for 0.38% of the portfolio, ranked #72.

Park National Corp first reported a position in AZN in Q3 2018 and has held it in 32 quarters since. The position peaked at $16.6M in Q3 2020. 488 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Park National Corp held 71,820 shares of AstraZeneca worth $13.6M as of Q2 2026.
  • Park National Corp sold 1,511 AstraZeneca shares in Q2 2026, an estimated $284K.
  • AstraZeneca made up 0.38% of Park National Corp's portfolio in Q2 2026, its #72 holding.
  • Park National Corp first reported a position in AstraZeneca in Q3 2018 and has held it in 32 quarters since.
  • Park National Corp's AstraZeneca position peaked at $16.6M in Q3 2020.
  • 488 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.